摘要
目的:评估医联体共同构建微信平台用于指导冠心病患者对应规范化治疗的意义。方法:2018年11月-2020年9月收治冠心病患者400例,随机分为两组,各200例。试验组给予微信平台一对一指导规范化治疗干预;对照组给予门诊常规治疗干预。比较两组心血管事件发生率、冠脉介入手术率及服药依从性评分。结果:试验组心血管事件发生率及冠脉介入手术率均低于对照组,且服药依从性评分高于对照组,差异均有统计学意义(P<0.05)。结论:医联体共同构建微信平台有利于指导冠心病患者接受规范化治疗。
Objective:To evaluate the significance of joint construction of WeChat platform by medical consortium to guide the corresponding standardized treatment for patients with coronary heart disease.Methods:From November 2018 to September 2020,400 patients with coronary heart disease were selected and randomly divided into two groups with 200 patients in each group.The experimental group was given one-to-one guidance of WeChat platform for standardized treatment intervention.The control group received outpatient conventional treatment intervention.The incidence of cardiovascular events,coronary intervention rate and medication compliance scores were compared between the two groups.Results:The incidence of cardiovascular events and the rate of coronary intervention in the experimental group were lower than the control group,and the medication compliance score was higher than the control group,with the differences were statistically significant(P<0.05).Conclusion:The joint establishment of WeChat platform by medical consortium is beneficial to guide patients with coronary heart disease to receive standardized treatment.
作者
吴月娥
Wu Yue'e(Outpatient Department Office,Fourth Hospital of Changsha City,Hunan Changsha 410006)
出处
《中国社区医师》
2021年第15期182-183,共2页
Chinese Community Doctors
基金
长沙市科技局(医联体共建微信平台指导冠心病患者规范化治疗应用研究,课题编号:ZD1802014)
关键词
医联体
微信平台
冠心病
规范化治疗
Medical consortium
WeChat platform
Coronary heart disease
Standardized treatment
